Most Patent Progress readers are probably familiar with the PREVAIL Act—legislation that is pending before the Senate Judiciary Committee that would sharply limit access to PTABPatent Trial and Appeal Board. Reviews adverse decisions of examiners on written appeals of applicants and appeals of reexaminations, and conducts inter partes reviews and post-grant reviews. The Board also continues to decide patent interferences, as it was known as the Board of Patent Appeals and Interferences (BPAI) before the AIA. review. I recently wrote an article for Law360 that describes the various ways in which PREVAIL would undermine PTABPatent Trial and Appeal Board. Reviews adverse decisions of examiners on written appeals of applicants and appeals of reexaminations, and conducts inter partes reviews and post-grant reviews. The Board also continues to decide patent interferences, as it was known as the Board of Patent Appeals and Interferences (BPAI) before the AIA. proceedings—and how this legislation is just the latest phase in a campaign to insulate invalid patents from scrutiny.
Among its various misguided “reforms,” PREVAIL imposes a single-petition rule that would make it impossible to challenge patents with numerous or complex claims. The bill would also require the Board to defer to a district court’s rejection of a validity challenge, and it would penalize litigation defendants who seek PTABPatent Trial and Appeal Board. Reviews adverse decisions of examiners on written appeals of applicants and appeals of reexaminations, and conducts inter partes reviews and post-grant reviews. The Board also continues to decide patent interferences, as it was known as the Board of Patent Appeals and Interferences (BPAI) before the AIA. review.
Advocates of PREVAIL ignore the fact that the PTABPatent Trial and Appeal Board. Reviews adverse decisions of examiners on written appeals of applicants and appeals of reexaminations, and conducts inter partes reviews and post-grant reviews. The Board also continues to decide patent interferences, as it was known as the Board of Patent Appeals and Interferences (BPAI) before the AIA. is uniquely qualified to adjudicate patent validity disputes. All PTABPatent Trial and Appeal Board. Reviews adverse decisions of examiners on written appeals of applicants and appeals of reexaminations, and conducts inter partes reviews and post-grant reviews. The Board also continues to decide patent interferences, as it was known as the Board of Patent Appeals and Interferences (BPAI) before the AIA. judges have a technical education. This ensures that a panel will have at least a background knowledge of the technology at issue—and can decide the case based on a thorough understanding of the scientific evidence. This adds an element of predictability and reliability to PTABPatent Trial and Appeal Board. Reviews adverse decisions of examiners on written appeals of applicants and appeals of reexaminations, and conducts inter partes reviews and post-grant reviews. The Board also continues to decide patent interferences, as it was known as the Board of Patent Appeals and Interferences (BPAI) before the AIA. adjudications that is often sorely lacking in civil litigation.
I hope that the Judiciary Committee will decline to report the PREVAIL Act. Having less accurate decisions on challenges to a patent’s validity will not contribute to our nation’s innovation economy.
